An Ad5-vectored HIV-1 vaccine elicits cell-mediated immunity but does not affect disease progression in HIV-1-infected male subjects: results from a randomized placebo-controlled trial (the Step study).
Saved in:
| Title: | An Ad5-vectored HIV-1 vaccine elicits cell-mediated immunity but does not affect disease progression in HIV-1-infected male subjects: results from a randomized placebo-controlled trial (the Step study). |
|---|---|
| Authors: | Fitzgerald DW (AUTHOR), Janes H (AUTHOR), Robertson M (AUTHOR), Coombs R (AUTHOR), Frank I (AUTHOR), Gilbert P (AUTHOR), Loufty M (AUTHOR), Mehrotra D (AUTHOR), Duerr A (AUTHOR), Step Study Protocol Team (CORPORATE AUTHOR), Fitzgerald, D W1 (AUTHOR), Janes, H (AUTHOR), Robertson, M (AUTHOR), Coombs, R (AUTHOR), Frank, I (AUTHOR), Gilbert, P (AUTHOR), Loufty, M (AUTHOR), Mehrotra, D (AUTHOR), Duerr, A (AUTHOR) |
| Source: | Journal of Infectious Diseases. 2011, Vol. 203 Issue 6, p765-772. 8p. |
| Database: | Environment Complete |
| ISSN: | 00221899 |
|---|---|
| DOI: | 10.1093/infdis/jiq114 |
